Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing
15/05/2026 21:49
May 15 (Reuters) - Ensysce Biosciences Inc ENSC.O: ENSYSCE BIOSCIENCES INC - LAUNCHES FORMAL REVIEW OF STRATEGIC ALTERNATIVES - SEC FILING Source text: [ID:n0001493152-26-023810] Further company coverage: ENSC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing